Results 111 to 120 of about 17,105 (305)

The effects of planform solidity in the limit of low frontal solidity on wall-bounded turbulent flow over rough surfaces [PDF]

open access: yes
The effects of planform solidity, i.e., coverage by roughness features, are investigated in the limit of low frontal solidity using direct numerical simulations of turbulent channel flow over surfaces covered by pyramid-shaped roughness elements.
Busse, Angela, Zhdanov, Oleksandr
core  

Continuity vs Solidity

open access: yes, 2020
Data from the experiments reported in "Core cognition in adult vision: A surprising discrepancy between the principles of object continuity and solidity", by Falck, Labouret, Izard, Wertz, Keil & Strickland (JEP:General, July 13, 2020)
Andreas Falck   +5 more
core  

AST urskilning för Solidity

open access: yes
Code differencing plays a crucial role in modern software engineering, helping developers quickly identify changes between versions. To enhance the accuracy and utility of these comparisons, Abstract Syntax Tree (AST) differencing provides a higher ...
Åryd, Viktor
core   +1 more source

The utilization of Solidity programming language in blockchain

open access: yesVojnotehnički Glasnik
Introduction/purpose: This work provides a comprehensive overview of blockchain technology, elucidating its foundational principles and how it ensures transparency, immutability, and decentralization.
Sava S. Stanišić   +2 more
doaj   +1 more source

Metastasis on pause: How dormant tumor cells stay hidden within the tumor microenvironment and evade immune surveillance

open access: yesMolecular Oncology, EarlyView.
Dormant cancer cells can hide in distant organs for years, evading treatment and the immune system. This review highlights how signals from the surrounding tissue and immune environment keep these cells inactive or trigger their reawakening. Understanding these mechanisms may help develop therapies to eliminate or control dormant cells and prevent ...
Kanishka Tiwary   +1 more
wiley   +1 more source

SIF: A Framework for Solidity Contract Instrumentation and Analysis [PDF]

open access: yes, 2019
Solidity is an object-oriented and high-level language for writing smart contracts that are used to execute, verify and enforce credible transactions on permissionless blockchains.
Sefa Akca   +5 more
core   +1 more source

Clinical performance of the urine‐based TERT promoter AbsoluteQ Digital PCR for non‐invasive detection of bladder cancer

open access: yesMolecular Oncology, EarlyView.
A urine‐based digital PCR assay targeting two hotspot TERT promoter variants detected bladder cancer with high sensitivity and no false positives in this case–control cohort. The streamlined AbsoluteQ workflow outperformed Sanger sequencing and supports non‐invasive molecular testing for bladder cancer detection.
Anna Nykel   +12 more
wiley   +1 more source

Developmental programmes drive cellular plasticity, disease progression and therapy resistance in lung adenocarcinoma

open access: yesMolecular Oncology, EarlyView.
This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska   +13 more
wiley   +1 more source

USP29‐regulated noncanonical stabilization of the hypoxia‐inducible factor‐α in aggressive prostate cancer

open access: yesMolecular Oncology, EarlyView.
We identify USP29 as the only DUB mirroring CA9 expression, a marker of hypoxia and HIF pathway activation associated with PCA aggressiveness. USP29 stabilizes HIF‐1α and HIF‐2α via a noncanonical mechanism that is independent of PHD/pVHL activity yet relies on proteasomal regulation, establishing USP29 as a previously unrecognized regulator of hypoxic
Amelie S Schober   +16 more
wiley   +1 more source

Longitudinal genome‐wide aneuploidy measurements in circulating cell‐free DNA to predict lack of benefit from pembrolizumab in patients with metastatic urothelial cancer

open access: yesMolecular Oncology, EarlyView.
Many patients with urothelial cancer do not benefit from treatment with pembrolizumab, while at risk of severe side effects. Changes in the levels of circulating tumor DNA early during treatment, measured by a simple and affordable assay that can be easily implemented in the clinic, can be used as a prognostic tool to identify these patients.
Youssra Salhi   +14 more
wiley   +1 more source

Home - About - Disclaimer - Privacy